作者:Hitendra N. Karade、B. N. Acharya、Manisha Sathe、M. P. Kaushik
DOI:10.1007/s00044-008-9089-0
日期:2008.4
A series of thiazole-derived N-Boc amino acids were synthesized and evaluated as targeted potential antimalarials against plasmepsins II enzyme of malaria parasite Plasmodium falciparum. All the compounds showed moderate to good activity. Compounds 3f and 3g were found to have highest the 50% inhibitory concentration (IC50) values (3.45 μM and 4.89 μM, respectively) against Plasmodium falciparum .
合成了一系列噻唑衍生的N-Boc氨基酸,并将其评估为针对疟原虫 恶性疟原虫 纤溶酶II 酶的 潜在潜在抗疟药 。 所有化合物均显示出中等至良好的活性。发现化合物 3f 和 3g 对 恶性疟原虫 的50%抑制浓度(IC 50)值最高(分别为3.45μM和4.89μM) 。化合物停靠在 纤溶酶II的活性位点 。 发现大多数化合物与 纤溶酶II的催化氨基酸ASP34和ASP214 相互作用 。在噻唑衍生物的结合能和抗寄生虫活性之间观察到良好的相关性。